4.0 Article

Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease

期刊

JOURNAL OF CLINICAL DENSITOMETRY
卷 19, 期 1, 页码 102-116

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jocd.2015.11.003

关键词

Bone Health ECHO; emerging; osteoporosis; Project ECHO; treatment

资金

  1. NPS
  2. Novartis
  3. Amgen
  4. Genzyme
  5. Eli Lilly
  6. Merck
  7. Lilly
  8. Merck Serono
  9. Boehringer Ingelheim
  10. Roche Diagnostics
  11. Takeda
  12. University of Alabama
  13. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109008] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The 2015 Santa Fe Bone Symposium was a venue for healthcare professionals and clinical researchers to present and discuss the clinical relevance of recent advances in the science of skeletal disorders, with a focus on osteoporosis and metabolic bone disease. Symposium topics included new developments in the translation of basic bone science to improved patient care, osteoporosis treatment duration, pediatric bone disease, update of fracture risk assessment, cancer treatment-related bone loss, fracture liaison services, a review of the most significant studies of the past year, and the use of telementoring with Bone Health Extension for Community Healthcare Outcomes, a force multiplier to improve the care of osteoporosis in underserved communities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据